MktsMarkets

Anika Therapeutics Inc.
NASDAQ: ANIKKey statistics
ANIK News
Stories mentioning ANIK from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 29,612 | 30,615 | 27,817 | 28,219 | 26,168 | 30,602 | 29,559 | 30,724 |
| Cost of Goods Sold | 10,615 | 11,436 | 12,233 | 13,856 | 11,487 | 13,476 | 10,151 | 10,235 |
| Gross Profit | 18,997 | 19,179 | 15,584 | 14,363 | 14,681 | 17,126 | 19,408 | 20,489 |
| Operating Expenses | ||||||||
| Research & Development | 6,713 | 6,452 | 6,946 | 6,313 | 6,059 | 6,507 | 5,946 | 6,682 |
| Sales General & Admin | 17,772 | 12,081 | 11,871 | 12,230 | 12,906 | 11,324 | 13,543 | 15,617 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (5,488) | 646.00 | (3,233) | (4,180) | (4,284) | (705.00) | (81.00) | (1,810) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (4,821) | 764.00 | (2,236) | (3,966) | (3,869) | 39.00 | 325.00 | (1,215) |
| Tax Provision | 235.00 | (1,037) | 939.00 | 681.00 | 89.00 | 2,525 | 2,170 | 1,326 |
| Net Income (Loss) | (5,056) | 292.00 | (2,329) | (3,970) | (4,873) | (21,865) | (29,918) | (88.00) |
| Earnings Per Share (Basic) | (0.37) | 0.02 | (0.16) | (0.28) | (0.34) | (1.49) | (2.03) | (0.01) |
| Earnings Per Share (Diluted) | (0.37) | 0.02 | (0.16) | (0.28) | (0.34) | (1.49) | (2.03) | 0.00 |
| Weighted Average Shares Outstanding (Basic) | 13,531 | 14,339 | 14,419 | 14,364 | 14,297 | 14,721 | 14,768 | 14,839 |
| Weighted Average Shares Outstanding (Diluted) | 13,531 | 14,339 | 14,419 | 14,517 | 14,297 | 14,721 | 14,768 | 14,856 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ANIK
Anika Therapeutics Inc. (NASDAQ: ANIK) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANIK. It last traded at $14.55 (Nov 6, 2026, 4:00 PM ET), down 24.7% on the day. That gives Anika Therapeutics a market capitalisation of $214.8M.
Over the past 52 weeks ANIK has traded between $9.01 and $22.88.
Revenue for the quarter ended Mar 31, 2026 was $29.6M; a net loss of $5.1M. Revenue was up 13.2% from $26.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $29.6M | -$5.1M | -17.1% |
| Dec 31, 2025 | $30.6M | $292.0K | 1.0% |
| Sep 30, 2025 | $27.8M | -$2.3M | -8.4% |
| Jun 30, 2025 | $28.2M | -$4.0M | -14.1% |
From Anika Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…